A New Biomarker in Acute-Decompensated Heart Failure. Preliminary Study

1. Zorlu A, Tandogan I, Yilmaz MB, et al. Burden of Systolic and Diastolic Ventricular. J Am Coll Cardiol. 2015;18(3):1-7. doi: 10.1159/00036060910.1159/000360609Open DOISearch in Google Scholar

2. McMurray JJ V, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart. Rev Port Cardiol. 2013;32(7-8):e1--641--e61. doi:10.1093/eurheartj/ehs10410.1093/eurheartj/ehs104Open DOISearch in Google Scholar

3. Turgut O, Tandogan I, Yilmaz MB, Gul I, Zorlu A. CA125 in heart failure: Implications for immunoinflammatory activity. Int J Cardiol. 2011;146(1):99-100. doi:10.1016/j.ijcard.2010.05.07710.1016/j.ijcard.2010.05.077Open DOISearch in Google Scholar

4. Huang F, Zhang K, Chen J, et al. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion. Clin Biochem. 2013;46(16-17):1694-1700. doi:10.1016/j.clinbiochem.2013.09.00810.1016/j.clinbiochem.2013.09.008Open DOISearch in Google Scholar

5. Monteiro S, Franco F, Costa S, et al. Prognostic value of CA125 in advanced heart failure patients. Int J Cardiol. 2010;140(1):115-118. doi:10.1016/j.ijcard.2008.11.02310.1016/j.ijcard.2008.11.023Open DOISearch in Google Scholar

6. Zorlu A, Tandogan I, Yilmaz MB. CA-125, an omitted part of the heart. Hear Lung Circ. 2011;20(5):345. doi:10.1016/j.hlc.2011.01.02510.1016/j.hlc.2011.01.025Open DOISearch in Google Scholar

7. Yilmaz MB, Nikolaou M, Solal AC. Tumour biomarkers in heart failure: Is there a role for CA-125? Eur J Heart Fail. 2011;13(6):579-583. doi:10.1093/eurjhf/hfr02210.1093/eurjhf/hfr022Open DOISearch in Google Scholar

8. Topatan B, Basaran A. CA-125 and heart failure: Deja vu or “still to be seen.” Int J Cardiol. 2010;145(3):626-629. doi:10.1016/j.ijcard.2010.09.06010.1016/j.ijcard.2010.09.060Search in Google Scholar

9. Napan S, Aussawapokee T, Nargileci E, Qureshi A, Khadra S, Stroger JH. Prognostic Significance of Carbohydrate Antigen 125 in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2010;55(10):A30.E292. doi:10.1016/S0735-1097(10)60293-810.1016/S0735-1097(10)60293-8Search in Google Scholar

10. Nunez J, Minana G, Nunez E, Sanchis J. Antigen carbohydrate 125 in heart failure: A promising clinical tool. Int J Cardiol. 2011;150(3):369-370. doi:10.1016/j.ijcard.2011.05.08910.1016/j.ijcard.2011.05.089Search in Google Scholar

11. Sánchez-Marteles M, Rubio Gracia J, Giménez López I. Pathophysiology of acute heart failure: a world to know. Rev Clin Esp. 2015;216(1):38-46. doi:10.1016/j.rce.2015.09.01010.1016/j.rce.2015.09.010Open DOISearch in Google Scholar

12. Kälsch H, Neumann T, Erbel R. Less increase of BNP and NT-proBNP levels in obese patient with decompensated heart failure. Interpretation of natriuretic peptides in obesity. Int J Cardiol. 2009;133(1):e22-e24. doi:10.1016/j.ijcard.2007.08.09810.1016/j.ijcard.2007.08.098Open DOISearch in Google Scholar

13. Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure. Int J Cardiol. 2014;176(3):611-617. doi:10.1016/j.ijcard.2014.08.00710.1016/j.ijcard.2014.08.007Open DOISearch in Google Scholar

14. Gentili A, Frangione MR, Albini E, et al. Modulation of natriuretic peptide receptors in human adipose tissue: molecular mechanisms behind the “natriuretic handicap” in morbidly obese patients. Transl Res. 2017;186:52-61. doi:10.1016/j.trsl.2017.06.00110.1016/j.trsl.2017.06.001Open DOISearch in Google Scholar

15. Kinoshita K, Kawai M, Minai K, Ogawa K, Inoue Y, Yoshimura M. Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: An approach using covariance structure analysis. Int J Cardiol. 2016;215:283-290. doi:10.1016/j.ijcard.2016.04.11110.1016/j.ijcard.2016.04.111Open DOISearch in Google Scholar

16. Ricci MA, De Vuono S, Pucci G, et al. Determinants of low levels of brain natriuretic peptide in morbid obesity. Clin Nutr. 2017;36(4):1075-1081. doi:10.1016/j.clnu.2016.06.02410.1016/j.clnu.2016.06.024Open DOISearch in Google Scholar